digestive/alimentary system
• lower sensitivity to dextran sodium sulfate (DSS)-induced colitis: reduced weight loss, reduced colon shortening, reduced colon histopathology score and lower expression of Il6 and Cxcl2 in colon
|
respiratory system
N |
• normal baseline lung function (functional residual, total lung inspiratory and vital capacity, transpulmonary and airway resistance, dynamic compliance and elastance, inertance, and tissue damping)
|
• increased dynamic and tissue elastance after methacholine challenge
• normal baseline elastance
|
• increased after methacholine challenge
|
• after methacholine challenge
• normal baseline tissue damping
|
• increased transpulmonary and airway resistance after methacholine challenge
• normal baseline transpulmonary and airway resistance
|
• decreased dynamic compliance after methacholine challenge
• normal baseline dynamic compliance
|
growth/size/body
N |
• normal organ histology
|
immune system
N |
• normal mast cell (MC) count and histology in ears and peritoneal cavity
• normal numbers of circulating monocytes, neutrophils and lymphocytes
|
• lower sensitivity to dextran sodium sulfate (DSS)-induced colitis: reduced weight loss, reduced colon shortening, reduced colon histopathology score and lower expression of Il6 and Cxcl2 in colon
|
mortality/aging
N |
• viable and normal lifespan
|
• lower sensitivity to dextran sodium sulfate (DSS)-induced colitis: reduced weight loss, reduced colon shortening, reduced colon histopathology score and lower expression of Il6 and Cxcl2 in colon
|
• lower sensitivity to smoke-induced COPD: no rise in macrophage and neutrophil counts in bronchial alveolar lavage fluid (BALF); attenuated rise of peribronchial, perivascular, and parenchymal inflammatory cells; reduced small airway fibrosis
|
embryo
N |
• no obvious developmental abnormalities
|